ING Group’s Insmed INSM Stock Holding History

ING Group’s Portfolio INSM Stock Details INSM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$980K	Sell	5,996 -116,949	-95%	-$18M	0.01%	436
2025 Q4	$21.4M	Sell	122,945 -250,555	-67%	-$45.7M	0.13%	127
2025 Q3	$53.8M	Buy	+373,500	New	+$45.8M	0.29%	63

Other funds holding INSM

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

DGM

Darwin Global Management St. Helier, Jersey $3.77B AUM 307.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

ING Group's INSM Position: Q1 2026 in Review

ING Group reduced its Insmed (INSM) stake by 95% in Q1 2026, selling an estimated $18M and leaving 5,996 shares worth $980K. The position accounts for 0.01% of the portfolio, ranked #436.

ING Group first reported a position in INSM in Q3 2025 and has held it in 3 quarters since. The position peaked at $53.8M in Q3 2025. 669 funds tracked by Wall St. Rank hold INSM as of Q1 2026.

ING Group held 5,996 shares of Insmed worth $980K as of Q1 2026.
ING Group sold 116,949 Insmed shares in Q1 2026, an estimated $18M.
Insmed made up 0.01% of ING Group's portfolio in Q1 2026, its #436 holding.
ING Group first reported a position in Insmed in Q3 2025 and has held it in 3 quarters since.
ING Group's Insmed position peaked at $53.8M in Q3 2025.
669 funds tracked by Wall St. Rank held Insmed as of Q1 2026.

Based on ING Group's 13F filing for Q1 2026, filed 11 May 2026.